Pharmacogenetics of unboosted atazanavir in HIV-infected individuals in resource-limited settings: a sub-study of the AIDS Clinical Trials Group (ACTG) PEARLS study (NWCS 342)

OBJECTIVES: The multinational PEARLS (ACTG A5175) study, conducted mainly in resource-limited settings, identified an increased treatment failure rate among HIV-infected individuals randomized to once-daily unboosted atazanavir, didanosine-EC, and emtricitabine compared with efavirenz-based regimens...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Antimicrob Chemother
Main Authors: Castillo-Mancilla, Jose R., Aquilante, Christina L., Wempe, Michael F., Smeaton, Laura M., Firnhaber, Cynthia, LaRosa, Alberto M., Kumarasamy, Nagalingeswaran, Andrade, Adriana, Baheti, Gautam, Fletcher, Courtney V., Campbell, Thomas B., Haas, David W., MaWhinney, Samantha, Anderson, Peter L.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2016
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867099/
https://ncbi.nlm.nih.gov/pubmed/26892777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw005
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki